-+ 0.00%
-+ 0.00%
-+ 0.00%

ARCELLX SHARES UP 10% AFTER CO ANNOUNCES POSITIVE DATA FROM MID-STAGE TRIAL OF ITS CANCER THERAPY FOR MULTIPLE MYELOMA

Reuters·12/08/2025 14:32:31

Please log in to view news